Ergoteles’s Origin Materials ORGN Stock Holding History

Ergoteles’s Portfolio ORGN Stock Details ORGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,297	Closed	-$179K	–	1628
2022 Q4	$179K	Buy	+1,297	New	+$207K	0.01%	1106

Other funds holding ORGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

KAM

Knightsbridge Asset Management Newport Beach, California $743M AUM 28.33% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Ergoteles's ORGN Position: Q1 2023 in Review

Ergoteles sold out of Origin Materials (ORGN) in Q1 2023, closing a stake of 1,297 shares — an estimated $179K sold.

Ergoteles first reported a position in ORGN in Q4 2022 and held it in 1 quarter. The position peaked at $179K in Q4 2022. 124 funds tracked by Wall St. Rank hold ORGN as of Q1 2023.

Ergoteles reported no remaining Origin Materials position as of Q1 2023 after selling out during the quarter.
Ergoteles sold 1,297 Origin Materials shares in Q1 2023, an estimated $179K.
Ergoteles first reported a position in Origin Materials in Q4 2022 and held it in 1 quarter.
Ergoteles's Origin Materials position peaked at $179K in Q4 2022.
124 funds tracked by Wall St. Rank held Origin Materials as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.